인쇄하기
취소
|
The substance, which has been claimed the most for patent trials after enforcement of the Pharmaceutical Patent Linkage System, was turned out to be the overactive bladder treatment, mirabegron.
CEO Hong-gi Lee of B2Pharm, a monitoring company for patent trials, stated that there were the total 1,623 patent trial claims filed from 1 March to 23 April.
CEO Lee has given an indirect notice of f...